Die neuesten RARE Reports werden am 2024-05-18 aktualisiert: 2024-Q12023-Q42023-Q3
Ultragenyx Pharmaceutical  logo
Ultragenyx Pharmaceutical RARE
€ 38.24 -0.82%

Ultragenyx Pharmaceutical Kennzahlen 2011-2024 | RARE

Kennzahlen Jährlich Ultragenyx Pharmaceutical

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-5.8 -3.5 -12.6 -45.1 -6.0 -11.0 -6.5 -10.9 -14.2 -27.9 - - -

P/S

8.1 6.7 16.2 31.1 23.3 42.0 753.8 20180.4 - - - - -

EPS

-8.2 -10.1 -6.7 -3.1 -7.1 -1.7 -7.1 -6.2 -4.0 -2.2 -14.9 -14.2 -

EV (Enterprise Value)

4.53 B 3.51 B 5.99 B 8.31 B 2.46 B 2.16 B 1.98 B 2.59 B 2 B 1.66 B 2.11 M -82.2 M 1.49 M

EBITDA per Share

-7.39 -9.02 -5.44 -5.22 -7.35 -7.07 -7.61 -6.18 -3.98 -1.95 - - -

EV/EBITDA

-16.2 -24.3 -6.2 -6.6 -6.9 -10.3 -13.5 -29.4 - - -

PEG

-1.08 -0.46 13.28 -4.87 -0.17 -0.28 0.53 0.19 0.19 -0.33 - - -

P/B

12.8 7.0 6.2 7.3 3.7 3.6 5.1 5.7 3.9 9.0 - - -

P/CF

-7.4 -6.4 -16.8 -63.7 -7.0 -7.4 -7.8 -15.7 -18.6 -35.7 - - -

ROE %

-220.26 -200.69 -49.21 -16.16 -61.60 -32.45 -78.79 -51.87 -27.42 -32.34 - - -

ROA %

-40.69 -45.77 -29.82 -10.60 -35.47 -27.46 -61.57 -45.48 -26.02 -30.21 - - -

ROCE %

-206.67 -184.09 -41.38 -21.03 -41.09 -57.59 -78.37 -51.63 -27.79 -30.62 - - -

Current Ratio

1.2 1.3 2.5 2.9 2.4 6.5 4.6 6.7 16.1 15.5 - - -

DSO

47.8 34.6 26.8 37.7 80.2 63.5 361.4 - - - - - -

DIO

- - - - - 1245.7 138152.5 - - - - - -

DPO

- - - - - 3369.9 2600625.0 - - - - - -

Betriebszyklus

47.8 34.6 26.8 37.7 80.2 1309.1 138513.9 - - - - - -

Finanzkreislauf

47.8 34.6 26.8 37.7 80.2 -2060.8 -2462111.1 - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Ultragenyx Pharmaceutical

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-2.03 - -2.23 -2.25 -2.33 - -3.5 -2.26 -2.19 - -1.08 -1.81 -2.03 -0.37 -1.13 0.42 -2.05 -1.62 -1.96 -1.72 -1.82 -1.73 -1.74 -1.06 0.63 -1.89 -1.87 -1.72 -1.63 -1.75 -1.64 -1.46 -1.35 -1.42 -1.03 -0.83 -0.63 -0.52 -0.5 -0.45 -0.85 -4.98 -3.48 -3.32 -2.84 - - - - - - - -

EBITDA per Share

-1.86 - - - -2.12 - -3.21 -2.02 -1.91 - -1.32 -1.22 -1.54 - -0.68 -0.95 -1.98 - -1.93 -1.88 -1.82 - -1.45 -1.66 -1.87 - -1.89 -1.8 -1.64 - -1.61 -1.46 -1.36 - -1.02 -0.83 -0.63 - -0.49 -0.45 -0.47 - -2.05 -2.29 -1.91 - - - - - - - -

ROE %

-1252.36 -701.64 -753.92 -302.80 -202.26 -94.73 -102.55 -58.09 -47.36 -33.32 -35.40 -37.92 -21.68 -28.31 -40.58 -45.79 -61.52 -52.89 -52.97 -51.77 -48.33 -32.45 -39.34 -45.67 -56.02 -78.79 -72.52 -65.55 -58.55 -51.87 -47.23 -40.93 -34.52 -27.42 -26.07 -27.25 -28.99 -32.34 -8.16 11.67 30.50 46.87 31.75 20.48 9.00 - - - - - - - -

ROA %

-51.04 -36.94 -52.08 -54.33 -54.12 -38.13 -43.04 -32.81 -28.93 -21.53 -22.90 -23.41 -13.39 -14.52 -21.41 -25.94 -36.60 -35.47 -39.41 -41.59 -40.19 -27.46 -31.91 -35.92 -43.45 -61.57 -58.10 -53.96 -49.64 -45.48 -42.16 -37.17 -31.96 -26.02 -24.61 -25.60 -27.14 -30.21 -40.73 -46.85 -54.39 -58.79 -39.82 -25.69 -11.29 - - - - - - - -

ROCE %

- - -48.01 -96.01 -116.89 -86.04 -95.66 -57.28 -44.91 -28.24 -35.79 -33.73 -34.28 -36.43 -52.66 -61.33 -65.99 -41.14 -55.86 -54.35 -56.22 -46.15 -67.98 -75.09 -79.96 -60.53 -74.41 -66.46 -58.25 -37.44 -44.96 -38.60 -32.03 -17.24 -25.81 -26.85 -28.56 -21.54 -11.17 7.77 26.18 30.41 30.41 20.04 9.02 - - - - - - - -

Current Ratio

1.1 1.2 1.0 1.1 1.2 1.3 1.4 2.1 2.4 2.5 2.7 2.8 2.9 2.9 2.1 2.1 2.0 2.4 2.4 2.4 2.4 6.5 6.5 6.5 6.5 4.6 4.6 4.6 4.6 8.1 8.1 8.1 8.1 19.6 19.6 19.6 19.6 15.2 15.2 15.2 15.2 6.2 6.2 6.2 6.2 - - - - - - - -

DSO

- - - - - - - - 32.4 - 28.0 26.1 22.1 23.0 25.9 34.1 70.3 84.2 116.2 124.1 114.5 71.5 98.8 90.9 76.5 195.5 2383.6 - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - 1375.4 1878.6 - 2361.5 4572.2 1586.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - 1533.3 2538.2 - 4102.9 7943.9 4291.0 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - 32.4 - 28.0 26.1 22.1 23.0 25.9 34.1 70.3 84.2 116.2 1499.5 1993.0 71.5 2460.3 4663.1 1662.7 195.5 2383.6 - - - - - - - - - - - - - - - - - - - - - - - - - -

Finanzkreislauf

- - - - - - - - 32.4 - 28.0 26.1 22.1 23.0 25.9 34.1 70.3 84.2 116.2 -33.7 -545.2 71.5 -1642.6 -3280.9 -2628.3 195.5 2383.6 - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung